drugset / Trial / NCT00027417

Study of Triostat in Infants During Heart Surgery

NCT00027417

Phase 3 Completed 195 enrolled Michael Portman
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease during cardiopulmonary bypass surgery.

Timeline

Start
2001-04
Primary completion
2007-08
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Liothyronine Small molecule Intravenous